Multiregional Glioma Single-Cell Transcriptomic Sequencing
Kai Yu
2020
2020/7/22
United States, Cabin John
Peking University

数据描述

Multiregional Glioma Single-Cell Transcriptomic Sequencing

Glioma is a complex malignant neoplasm, treating each case as a dark box obviously could not acquire expected overall prognosis, because subpopulation inside tumor could be core factor which directly influence tumor progression. So, clonal sequencing or single-cell sequencing could be best solution to this problem. Here we combined these two strategies and analyzed more than 6000 single-cell transcriptome of 73 surgery points from 13 glioma and 1 brain metastasis patient. After these cells assigned into normal, immune, tumor and several other groups based on differentially expressed genes and specified TCGA 4 classification gene sets, spacial information of sampling points helped us built up cell type constituent of different part inside tumor, and illustrated invasion patterns during tumor growth.

关键词

1
Homo sapiens

数据列表

6

SOFT formatted family file(s)

格式SOFT
下载

MINiML formatted family file(s)

格式MINiML
下载

Series Matrix File(s)

格式TXT
下载

GSE117891_RAW.tar

格式TAR (of TSV)
大小53.1 Mb
下载

GSE117891_Sample_barcode_cell_information.xlsx

格式XLSX
大小225.6 Kb
下载

GSE117891_all_6148.umi.count.matrix.tsv.gz

格式TSV
大小39.1 Mb
下载
www.ncbi.nlm.nih.gov
IP: 130.14.29.110
访问数据源
加载中...

相关论文

7

macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma

Ana NikolicFrancesca MauleAnna BobynKatrina EllestadSeungil Paik30
Nature Communications
2023
2023/5/27
Vol.14 No.1 p.1-22
Self-renewal is a crucial property of glioblastoma cells that is enabled by the choreographed functions of chromatin regulators and transcription factors. Identifying targetable epigenetic mechanisms of self-renewal could therefore represent an important step toward developing effective treatments f...
Cancer genomicsCancer modelsCancer stem cellsCNS cancerMechanisms of disease
10.1038/S41467-023-38919-2
ISSN:2041-1723

High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity

Sohyon LeeTobias WeissMarcel BühlerJulien MenaZuzanna Lottenbach25
Nature Medicine
2024
2024/9/20
00 p.1-13
Glioblastoma, the most aggressive primary brain cancer, has a dismal prognosis, yet systemic treatment is limited to DNA-alkylating chemotherapies. New therapeutic strategies may emerge from exploring neurodevelopmental and neurophysiological vulnerabilities of glioblastoma. To this end, we systemat...
CNS cancerMachine learningPhenotypic screeningSingle-cell imagingTranslational research
10.1038/S41591-024-03224-Y
ISSN:1078-8956

A brain cell atlas integrating single-cell transcriptomes across human brain regions

Xinyue ChenYin HuangLiangfeng HuangZiliang HuangZhao-Zhe Hao14
Nature Medicine
2024
2024/8/2
00 p.1-13
While single-cell technologies have greatly advanced our comprehension of human brain cell types and functions, studies including large numbers of donors and multiple brain regions are needed to extend our understanding of brain cell heterogeneity. Integrating atlas-level single-cell data presents a...
Genetic databasesRNA sequencing
10.1038/S41591-024-03150-Z
ISSN:1078-8956

GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells

Asmita PathakPalavalasa SravyaBruno ColonErika CiervoYadi Zhou38
Nature Cancer
2026
2026/6/23
00 p.1-14
Sex differences in immune responses impact cancer outcomes and treatment response, including in glioblastoma (GBM). However, host factors underlying distinct immune-cancer interactions are poorly understood. Here we identify γ-aminobutyric acid (GABA) as a female-specific driver of GBM-promoting imm...
CancerCNS cancerTumour immunology
10.1038/S43018-026-01192-5
ISSN:2662-1347

Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression

Chenfei LuTao KangJunxia ZhangKailin YangYang Liu47
Nature Communications
2025
2025/3/26
Vol.16 No.1 p.1-21
Glioblastoma (GBM) is the most lethal primary brain tumor with intra-tumoral hierarchy of glioblastoma stem cells (GSCs). The heterogeneity of GSCs within GBM inevitably leads to treatment resistance and tumor recurrence. Molecular mechanisms of different cellular state GSCs remain unclear. Here, we...
Cancer stem cellsCNS cancer
10.1038/S41467-025-58366-5
ISSN:2041-1723

Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities

Luciano GarofanoSimona MigliozziYoung Taek OhFulvio D’AngeloRyan D. Najac22
Nature Cancer
2021
2021/1/11
Vol.2 No.2 p.141-156
The transcriptomic classification of glioblastoma (GBM) has failed to predict survival and therapeutic vulnerabilities. A computational approach for unbiased identification of core biological traits of single cells and bulk tumors uncovered four tumor cell states and GBM subtypes distributed along n...
CancerCancer metabolismCNS cancer
10.1038/S43018-020-00159-4
ISSN:2662-1347

A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data

De Falco AntonioCaruso FrancescaSu Xiao-DongIavarone AntonioCeccarelli Michele
Nature Communications
2023
2023/2/25
Vol.14 No.1 p.1-13
Single-cell RNA sequencing is the reference technology to characterize the composition of the tumor microenvironment and to study tumor heterogeneity at high resolution. Here we report Single CEll Variational ANeuploidy analysis (SCEVAN), a fast variational algorithm for the deconvolution of the clo...
Cancer genomicsCancer microenvironmentComputational biology and bioinformaticsMathematics and computingTumour heterogeneity
10.1038/S41467-023-36790-9
ISSN:2041-1723